Literature DB >> 26980776

Circulating miR-130a, miR-27b, and miR-210 in Patients With Peripheral Artery Disease and Their Potential Relationship With Oxidative Stress.

Salvatore Santo Signorelli1, Guido Li Volsi2, Alessandro Pitruzzella3, Valerio Fiore1, Marco Mangiafico1, Luca Vanella4, Rosalba Parenti2, Manfredi Rizzo5, Giovanni Li Volti2.   

Abstract

Some emerging risk factors such as oxidative stress biomarkers and microRNAs (miRs) may add additional value to the established risk factors for peripheral artery disease (PAD). We enrolled 27 patients with PAD and 27 age-matched controls. We examined the levels of a series of miRs (miR-130a, miR-27b, and miR-210) in serum samples. The level of well-established oxidative stress biomarkers, such as lipid hydroperoxides, isoprostanes, hemeoxygenase-1 (HO-1) and reduced glutathione, was also measured in plasma and their relationship with the miRs was determined. Levels of miR-130a, miR-27b, and miR-210 were significantly increased in patients with PAD when compared to the controls. The level of miR-130 was positively correlated with body mass index, whereas miR-210 was inversely associated with pain-free walking distance (PfWD). None of the evaluated miRs was associated with lowered PfWD of patients with PAD (stage IIa > 250 m, IIb < 250 m) or oxidative stress parameters. In conclusion, our findings suggest the need for more research to assess if miRs can serve as useful markers for the early diagnosis and monitoring of PAD.

Entities:  

Keywords:  Heme Oxygenase; biomarker; microRNA; oxidative stress; peripheral arterial disease

Mesh:

Substances:

Year:  2016        PMID: 26980776     DOI: 10.1177/0003319716638242

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  21 in total

1.  Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects.

Authors:  Tamas Kiss; Cory B Giles; Stefano Tarantini; Andriy Yabluchanskiy; Priya Balasubramanian; Tripti Gautam; Tamas Csipo; Ádám Nyúl-Tóth; Agnes Lipecz; Csaba Szabo; Eszter Farkas; Jonathan D Wren; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-08-28       Impact factor: 7.713

Review 2.  Biomarkers and Genetics in Peripheral Artery Disease.

Authors:  Surovi Hazarika; Brian H Annex
Journal:  Clin Chem       Date:  2016-11-21       Impact factor: 8.327

3.  Endothelial Cell Inflammation and Antioxidant Capacity are Associated With 6-Minute Walk Performance in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Yan D Zhao; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  Angiology       Date:  2017-08-24       Impact factor: 3.619

Review 4.  Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review.

Authors:  Tiago Pereira-da-Silva; Madalena Coutinho Cruz; Catarina Carrusca; Rui Cruz Ferreira; Patrícia Napoleão; Miguel Mota Carmo
Journal:  Am J Cardiovasc Dis       Date:  2018-02-05

5.  Skeletal muscle MiR-210 expression is associated with mitochondrial function in peripheral artery disease patients.

Authors:  Ahmed Ismaeel; Emma Fletcher; Dimitrios Miserlis; Marissa Wechsler; Evlampia Papoutsi; Gleb Haynatzki; Robert S Smith; William T Bohannon; Panagiotis Koutakis
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

6.  Application of OpenArray RT-qPCR for identification of microRNA expression signatures of lower extremity artery disease.

Authors:  Daniel P Zalewski; Karol P Ruszel; Andrzej Stępniewski; Dariusz Gałkowski; Marcin Feldo; Janusz Kocki; Anna Bogucka-Kocka
Journal:  J Appl Genet       Date:  2022-04-02       Impact factor: 2.653

7.  Gene Expression Signature in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Jonathan D Newman; MacIntosh G Cornwell; Hua Zhou; Caron Rockman; Adriana Heguy; Yajaira Suarez; Henry S Cheng; Mark W Feinberg; Judith S Hochman; Kelly V Ruggles; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-04       Impact factor: 8.311

Review 8.  Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.

Authors:  Joshua P H Neale; James T Pearson; Rajesh Katare; Daryl O Schwenke
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-13       Impact factor: 5.555

9.  Plasma microRNAs levels are different between pulmonary and extrapulmonary ARDS patients: a clinical observational study.

Authors:  Yi Zheng; Song-Qiao Liu; Qin Sun; Jian-Feng Xie; Jing-Yuan Xu; Qing Li; Chun Pan; Ling Liu; Ying-Zi Huang
Journal:  Ann Intensive Care       Date:  2018-02-13       Impact factor: 6.925

Review 10.  The non-canonical functions of the heme oxygenases.

Authors:  Luca Vanella; Ignazio Barbagallo; Daniele Tibullo; Stefano Forte; Agata Zappalà; Giovanni Li Volti
Journal:  Oncotarget       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.